Actively Recruiting

Phase 2
Age: 18Years - 40Years
All Genders
NCT06260072

Magnesium and Riboflavin Treatment for Post-Concussion Headache

Led by University of Virginia · Updated on 2025-03-27

108

Participants Needed

1

Research Sites

307 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This clinical trial will try to determine if the supplements magnesium and riboflavin will reduce the pain and duration of headaches in persons diagnosed with a concussion. The participant will be randomized to either active magnesium and riboflavin capsules or placebo (inert) capsules. The capsules will be taken once a day for 14 days. The participant will also complete a short diary form for the 14 days and will have 3 follow up visits either by telephone or in person.

CONDITIONS

Official Title

Magnesium and Riboflavin Treatment for Post-Concussion Headache

Who Can Participate

Age: 18Years - 40Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Seen at University of Virginia Student Health and Wellness Center or Emergency Department for Initial Visit for Concussion
  • Less than 3 days have elapsed since their injury
  • Able to swallow capsules
Not Eligible

You will not qualify if you...

  • Concussion complicated by cranial bleed, skull fracture, or additional severe injury
  • Kidney dysfunction or failure
  • Significant gastrointestinal dysfunction
  • Varsity athlete
  • Two or more previous concussions
  • Women who are pregnant or breastfeeding
  • Taking tetracycline, fluoroquinolone, iron digoxin, chlorpromazine, or penicillamine

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Virginia Student Health and Wellness Center

Charlottesville, Virginia, United States, 22903

Actively Recruiting

Loading map...

Research Team

S

Stephanie Hartman, MD

CONTACT

K

Karen Ahern, BSN MBA

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here